Exclusive investor event brings together scientific and financial minds for curated dialogue on advancing human healthspan.
As the longevity sector evolves from promising prospect to a discernible market category, its investment landscape is becoming notably more curated – and the Longevity Investors Conference (LIC), returning to Gstaad this September, appears intent on reflecting that shift. Billed as a closed-door gathering of qualified investors and leading scientists, LIC 2025 will again unfold at the Le Grand Bellevue hotel, offering a setting that combines alpine serenity with intellectual intensity.
Taking place from 22–25 September 2025, this sixth edition will focus on facilitating deeper engagement and carefully brokered exchanges, rather than sheer scale. The event’s format – which includes private roundtable discussions, structured matchmaking and informal outdoor networking – aims to foster the sort of candid dialogue that larger gatherings often dilute.
Longevity.Technology: As the longevity sector continues its transition from scientific frontier to strategic investment category, curated events like the Longevity Investors Conference and others play a crucial role in shaping how capital meets innovation. Set against the alpine backdrop of Gstaad, LIC has consistently positioned itself as more than just a meeting point – it is a carefully calibrated forum where high-conviction investors and seasoned domain experts can engage with nuance, rigor and candor. In a field that increasingly rewards discernment over hype, the emphasis on private dialogue, curated connections and long-term perspective feels both timely and necessary. The 2025 edition promises to deepen that formula, reflecting a sector no longer asking if longevity is investable, but how best to back the science with smart, sustained capital.
Speakers this year span the scientific and commercial breadth of the field: Drs Aubrey de Grey, João Pedro de Magalhães and Eric Verdin represent some of the best-known voices in geroscience, while investors such as Sergey Young and Garri Zmudze bring a portfolio-focused perspective to the conversation. Meanwhile, speakers like Amol Sarva and Sheila Lirio Marcelo reflect longevity’s growing appeal beyond biotech’s traditional boundaries.
The lineup also includes David Gobel, co-founder and CEO of the Methuselah Foundation, Jamie Justice, Executive Vice President of Health at XPRIZE and Executive Director of the XPRIZE Healthspan competition, Tina Woods, Founder and CEO of Collider Health, Joe Betts-LaCroix, CEO of Retro Biosciences and Alex Aliper, President of Insilico Medicine, a pioneer in applying AI to pharmaceutical R&D.
Investors meet innovation in a closed-door setting
The conference’s structure is clearly designed with capital deployment in mind; while research is discussed, it is investment in that research – and the translation thereof – that sits at the core. Sessions are categorized into Longevity Investments, General Longevity, Longevity Science and Personal Longevity, offering a framework for dialogue that balances breadth with depth.
According to Marc P Bernegger, Co-Founder of Longevity Investors, the conference seeks to build on its previous momentum: “We are building on the momentum of last year’s success and are committed to providing an even more impactful platform for fostering collaboration and driving investment in the longevity space.”
The event also maintains a strong emphasis on informality as a lever for meaningful exchange; activities include a mountaintop lunch in a newly selected location, a book signing with author Sergey Young and a closing gala dinner featuring a private tombola – this year’s prizes include a helicopter flight over Gstaad and a luxury hotel stay.
Longevity as a long-range investment theme
While longevity science continues to move rapidly – and occasionally controversially – toward clinic and consumer, the capital required to navigate that journey remains significant. Events such as LIC offer a necessary lens through which investment horizons can be discussed with both caution and conviction.
Tobias Reichmuth, also a Co-Founder, emphasized the scale of the opportunity. “The longevity sector is rapidly emerging as one of the most compelling investment themes of our time, with projections valuing it at over $600 billion by 2026,” he said. “With growing momentum and breakthroughs happening at pace, now is the perfect moment to raise awareness and equip investors with the knowledge to engage in this transformative space.”
LIC 2025 arrives at a time when the sector demands discernment as much as enthusiasm – and when thoughtful convening is arguably as vital as scientific progress. Gstaad may once again provide the altitude needed to take a longer view.
For more information on the Longevity Investors Conference 2025 or to apply, please CLICK HERE.
Photographs courtesy of Longevity Investors Conference
The post Longevity Investors Conference returns to Gstaad in September appeared first on Longevity.Technology – Latest News, Opinions, Analysis and Research.
